Novel anti-IL-17A inhibitor shows similar efficacy to biological therapies in IL-17-driven disorders
Sep. 1, 2023
Interleukin-17A (IL-17A) is a pro-inflammatory cytokine involved in the pathogenesis of inflammatory, immune-mediated diseases such as psoriasis, psoriatic arthritis and others.